Medical therapy of children with fibrous dysplasia

Journal of Bone and Mineral Research

Volumn 21, Issue SUPPL. 2, 2006, Pages

  Glorieux, Francis H ^a   Rauch, Frank ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846466468     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1359/jbmr.06s221     Document Type: Conference Paper

References (37)

1. Lichtenstein L, Jaffe HL, 1942 Fibrous dysplasia of bone. Arch Pathol 33: 777-816
2. Collins MT, Chebli C, Jones J, Kushner H, Consugar M, Rinaldo P, Wientroub S, Bianco P, Robey PG, 2001 Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 16: 806-813 (Pubitemid 32332290)
3. Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespak S, Gupta A, Hannon T, Econs MJ, Bianco P, Robey PG, 2003 FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112: 683-692 (Pubitemid 38057709)
4. Yamamoto T, 2006 Clinical approach to clarifying the mechanism of abnormal bone metabolism in McCune-Albright syndrome. J Bone Miner Metab 24: 7-10 (Pubitemid 41821496)
5. Kobayashi K, Imanishi Y, Koshiyama H, Miyauchi A, Wakasa K, Kawata T, Goto H, Ohashi H, Koyano HM, Mochizuki R, Miki T, Inaba M, Nishizawa Y, 2006 Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia. Life Sci 78: 2295-2301
6. Cole DE, Fraser FC, Glorieux FH, Jequier S, Marie PJ, Reade TM, Scriver CR, 1983 Panostotic fibrous dysplasia: A congenital disorder of bone with unusual facial appearance, bone fragility, hyperphosphatasemia, and hypophosphatemia. Am J Med Genet 14: 725-735 (Pubitemid 13115340)
7. Albright F, Butler AM, Hampton AO, Smith P, 1937 Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunctions, with precocious puberty in females. N Engl J Med 216: 727-746
8. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM, 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325: 1688-1695
9. Happle R, 1986 The McCune-Albright syndrome: A lethal gene surviving by mosaicism. Clin Genet 29: 321-324 (Pubitemid 16116576)
10. Schwindinger WF, Francomano CA, Levine MA, 1992 Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89: 5152-5156
11. Malchoff CD, Reardon G, MacGillivray DC, Yamase H, Rogol AD, Malchoff DM, 1994 An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion. J Clin Endocrinol Metab 78: 803-806
12. Shenker A, Weinstein LS, Sweet DE, Spiegel AM, 1994 An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 79: 750-755
13. Candeliere GA, Roughley PJ, Glorieux FH, 1997 Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone. Bone 21: 201-206 (Pubitemid 27395408)
14. Candeliere GA, Glorieux FH, Prud'homme J, St-Arnaud R, 1995 Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N Engl J Med 332: 1546-1551
15. Yamamoto T, Ozono K, Kasayama S, Yoh K, Hiroshima K, Takagi M, Matsumoto S, Michigami T, Yamaoka K, Kishimoto T, Okada S, 1996 Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome. J Clin Invest 98: 30-35 (Pubitemid 26243817)
16. Marie PJ, de Pollak C, Chanson P, Lomri A, 1997 Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol 150: 1059-1069
17. Riminucci M, Fisher LW, Shenker A, Spiegel AM, Bianco P, Gehron Robey P, 1997 Fibrous dysplasia of bone in the McCune-Albright syndrome: Abnormalities in bone formation. Am J Pathol 151: 1587-1600 (Pubitemid 27527922)
18. Riminucci M, Liu B, Corsi A, Shenker A, Spiegel AM, Robey PG, Bianco P, 1999 The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: Site-specific patterns and recurrent histological hallmarks. J Pathol 187: 249-258 (Pubitemid 29037056)
19. Harris WH, Dudley HR, Barry RJ, 1962 The natural history of fibrous dysplasia. J Bone Joint Surg Am 44: 207-233
20. Terpstra L, Rauch F, Plotkin H, Travers R, Glorieux FH, 2002 Bone mineralization in polyostotic fibrous dysplasia: Histomorphometric analysis. J Bone Miner Res 17: 1949-1953 (Pubitemid 35239195)
21. Dent CE, Gertner JM, 1976 Hypophosphataemic osteomalacia in fibrous dysplasia. Q J Med 45: 411-420
22. Tanaka T, Suwa S, 1977 A case of McCune-Albright syndrome with hyperthyroidism and vitamin D-resistant rickets. Helv Paediatr Acta 32: 263-273 (Pubitemid 8185476)
23. Zung A, Chalew SA, Schwindinger WF, Levine MA, Phillip M, Jara A, Counts DR, Kowarski AA, 1995 Urinary cyclic adenosine 3′,5′-monophosphate response in McCune-Albright syndrome: Clinical evidence for altered renal adenylate cyclase activity. J Clin Endocrinol Metab 80: 3576-3581
24. Ruggieri P, Sim FH, Bond JR, Unni KK, 1994 Malignancies in fibrous dysplasia. Cancer 73: 1411-1424 (Pubitemid 24072547)
25. Stephenson RB, London MD, Hankin FM, Kaufer H, 1987 Fibrous dysplasia. An analysis of options for treatment. J Bone Joint Surg Am 69: 400-409 (Pubitemid 17067959)
26. Ozaki T, Sugihara M, Nakatsuka Y, Kawai A, Inoue H, 1996 Polyostotic fibrous dysplasia. A long-term follow up of 8 patients. Int Orthop 20: 227-232 (Pubitemid 26280277)
27. Bell NH, Avery S, Johnston CC, 1970 Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia. J Clin Endocrinol Metab 31: 283-290
28. Yamamoto K, Maeyama I, Kishimoto H, Morio Y, Harada Y, Ishitobi K, Ishikawa J, 1983 Suppressive effect of elcatonin, an eel calcitonin analogue, on excessive urinary hydroxyproline excretion in polyostotic fibrous dysplasia (McCune-Albright's syndrome). Endocrinol Jpn 30: 651-656 (Pubitemid 14192639)
29. Hjelmstedt A, Ljunghall S, 1979 A case of Albright's syndrome treated with calcitonin. Acta Orthop Scand 50: 251-253 (Pubitemid 9219812)
30. Chapurlat RD, Delmas PD, Liens D, Meunier PJ, 1997 Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 12: 1746-1752 (Pubitemid 27422377)
31. Pfeilschifter J, Ziegler R, 1998 Effect of pamidronate on clinical symptoms and bone metabolism in fibrous dysplasia and McCune-Albright syndrome. Med Klin 93: 352-359. (Pubitemid 28307770)
32. Lane JM, Khan SN, O'Connor WJ, Nydick M, Hommen JP, Schneider R, Tomin E, Brand J, Curtin J, 2001 Bisphosphonate therapy in fibrous dysplasia. Clin Orthop 382: 6-12. (Pubitemid 32047423)
33. Lala R, Matarazzo P, Bertelloni S, Buzi F, Rigon F, de Sanctis C, 2000 Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatr 89: 188-193 (Pubitemid 30339591)
34. Zacharin M, O'Sullivan M, 2000 Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome. J Pediatr 137: 403-409
35. Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH, 2003 Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone. J Clin Endocrinol Metab 88: 4569-4575 (Pubitemid 37357495)
36. Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R, 1998 Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339: 947-952 (Pubitemid 28455096)
37. Weinstein RS, 1997 Long-term aminobisphosphonate treatment of fibrous dysplasia: Spectacular increase in bone density. J Bone Miner Res 12: 1314-1315. (Pubitemid 27334979)